CancerNext®
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000560509.11
- Last updated: 2023-04-07
- Test version history
- 560509.11, last updated: 2023-04-07
- 560509.10, last updated: 2022-07-29
- 560509.9, last updated: 2022-05-03
- 560509.8, last updated: 2022-04-22
- 560509.7, last updated: 2020-07-22
- 560509.6, last updated: 2020-04-27
- 560509.5, last updated: 2019-10-24
- 560509.4, last updated: 2019-04-24
- 560509.3, last updated: 2019-04-22
- 560509.2, last updated: 2018-04-26
- 560509.1, last updated: 2018-03-23
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Hereditary cancer
Offered by Ambry Genetics
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.